{"id":"W4245102325","doi":"10.1200/jco.2017.35.15_suppl.2587","title":"A phase IB study of the combination of selumetinib (AZD6244, ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Selumetinib; Medicine; Colorectal cancer; MEK inhibitor; Internal medicine; KRAS; Rash; Oncology; Adverse effect; Cancer; Pharmacology; MAPK/ERK pathway; Kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001140748,0.001356281,0.001471295,0.0004802583,0.0004105954,0.000897011,0.0008537003,0.0009077797,0.00306305],"category_scores_gemma":[0.0005693582,0.0005650648,0.001037176,0.0004347919,0.0007377358,0.0008541743,0.0003609938,0.003052533,0.0009149976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001065442,"about_ca_system_score_gemma":0.00143671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000890538,"about_ca_topic_score_gemma":0.002959346,"domain_scores_codex":[0.9996884,0.0001229254,0.00001606746,0.00006476953,0.00003607836,0.00007172056],"domain_scores_gemma":[0.9994602,0.00005517253,0.00008826084,0.00005172802,0.00003381605,0.000310802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5725402,0.1704549,0.01819968,0.00083576,0.002117699,0.0006940753,0.0005991319,0.005817784,0.09839897,0.0004924783,0.006393018,0.1234562],"study_design_scores_gemma":[0.351613,0.6136659,0.01977006,0.00003260099,0.0005373058,0.0007086375,0.0001088808,0.001804554,0.007772973,0.0001921173,0.003754739,0.00003915941],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937592,0.0009690463,0.0003426519,0.0002856094,0.00005735923,0.00203955,0.000783668,0.0000712101,0.001691821],"genre_scores_gemma":[0.9923134,0.000925531,0.001210046,0.0004524534,0.00007289759,0.001505016,0.0020031,0.00002193139,0.001495621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00306305,"threshold_uncertainty_score":0.01024693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05563615848459411,"score_gpt":0.4590854484056294,"score_spread":0.4034492899210353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}